The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy

por Kowalska, Klaudia, Wilczopolski, Piotr, Buławska, Dominika, Młynarska, Ewelina, Rysz, Jacek, Franczyk, Beata
Publicado 2022

New Insights into the Use of Empagliflozin—A Comprehensive Review

por Forycka, Joanna, Hajdys, Joanna, Krzemińska, Julia, Wilczopolski, Piotr, Wronka, Magdalena, Młynarska, Ewelina, Rysz, Jacek, Franczyk, Beata
Publicado 2022